halichondria okadai
Recently Published Documents


TOTAL DOCUMENTS

25
(FIVE YEARS 2)

H-INDEX

12
(FIVE YEARS 2)

Marine Drugs ◽  
2019 ◽  
Vol 17 (8) ◽  
pp. 480 ◽  
Author(s):  
Takeshi Yamada ◽  
Ayano Fujii ◽  
Takashi Kikuchi

New diterpenes, namely, trichodermanins F–H, with a fused 6-5-6-6 ring system were isolated from the fungus Trichoderma harzianum OUPS-111D-4 separated from a marine sponge Halichondria okadai. These chemical structures were elucidated by 1D and 2D NMR as well as high-resolution fast atom bombardment mass spectrometry (HRFABMS) spectral analyses. We established their absolute stereostructures by application of the modified Mosher’s method or circular dichroism (CD) spectroscopy. In addition, their cytotoxicities were assessed using several cancer cell lines, with 1 and 2 exhibiting modest activities.


Tetrahedron ◽  
2018 ◽  
Vol 74 (27) ◽  
pp. 3742-3747 ◽  
Author(s):  
Sou Kikuchi ◽  
Kayo Okada ◽  
Yuko Cho ◽  
Shinichiro Yoshida ◽  
Eunsang Kwon ◽  
...  

2017 ◽  
Vol 2 (2) ◽  
pp. 873-874 ◽  
Author(s):  
Hana Kim ◽  
Hyung June Kim ◽  
Yun Hwan Jung ◽  
Cheol Yu ◽  
Yong Rock An ◽  
...  

2014 ◽  
Vol 03 (01) ◽  
pp. 057-059 ◽  
Author(s):  
Nishitha Shetty ◽  
Sudeep Gupta

AbstractEribulin is an anticancer drug approved for treatment of metastatic breast cancer. This drug is a synthetic derivative from Japanese marine sponge Halichondria okadai. It acts by interfering with the microtubular growth ultimately leading to apoptosis after prolonged mitotic blockage. In patients with metastatic breast cancer refractory to anthracyclines and taxanes, eribulin is one of the life-saving options. Neutropenia, neuropathy and QT prolongation are the most frequent adverse events associated with this drug. Phase I/II trials are also underway in refractory lung, ovarian, pancreatic, bladder, and soft tissue tumors. Larger prospective studies will define the role of this drug in a wide variety of tumors, and the future looks very promising.


2013 ◽  
Vol 23 (21) ◽  
pp. 5833-5835 ◽  
Author(s):  
Keiichi Konoki ◽  
Tatsuya Onoda ◽  
Sachie Furumochi ◽  
Yuko Cho ◽  
Mari Yotsu-Yamashita ◽  
...  

Toxins ◽  
2012 ◽  
Vol 4 (5) ◽  
pp. 323-338 ◽  
Author(s):  
Ryo Matsumoto ◽  
Yuki Fujii ◽  
Sarkar M. A. Kawsar ◽  
Robert A. Kanaly ◽  
Hidetaro Yasumitsu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document